2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci U S A. 2012;109(28):11252-7.
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov. 2012;2(3):236-47.
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. Clin Cancer Res. 2012;18(21):5911-23.
Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. Am J Pathol. 2012;180(3):1080-1094.
Amyloid β-Related Angiitis Causing Coma Responsive to Immunosuppression. Case Rep Pathol. 2012;2012:678746.
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma. Front Oncol. 2012;2:41.
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res. 2012;18(7):2032-8.
Emerging adverse cutaneous drug reactions. Dermatol Clin. 2012;30(4):695-730, vii.
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array. Br J Haematol. 2012;156(3):354-7.